郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Rutaecarpine and evodiamine selected as β1-AR inhibitor candidates using β1-AR/CMC-offline-UPLC/MS prevent cardiac ischemia-reperfusion injury via energy modulation.

期刊:Journal of pharmaceutical and biomedical analysis发表年份:2015作者:Hui Xue; Yongjie Cheng; Xin Wang; Yuan Yue; Weifang Zhang; Xiaoni Li

药效评价Screening β1AR inhibitors by cell membrane chromatography and offline UPLC/MS method for protecting myocardial ischemia.

期刊:Journal of pharmaceutical and biomedical analysis发表年份:2015作者:Yuan Yue; Lili Dou; Xin Wang; Hui Xue; Yanhong Song; Xiaoni Li

药效评价Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.

期刊:Bioorganic & medicinal chemistry发表年份:2015作者:Chaela S Presley; Suni M Mustafa; Ammaar H Abidi; Bob M Moore

药效评价Noribogaine is a G-protein biased κ-opioid receptor agonist.

期刊:Neuropharmacology发表年份:2015作者:Emeline L Maillet; Nicolas Milon; Mari D Heghinian; James Fishback; Stephan C Schürer; Nandor Garamszegi; Deborah C Mash